This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Human medicines European public assessment report (EPAR): Iscover, clopidogrel, ...
The Fierce Biotech Fundraising Tracker records venture capital rounds of $50 mil...
After striking its February deal with Carlyle and SK Capital, bluebird said it r...
Human medicines European public assessment report (EPAR): Elaprase, idursulfase,...
The WHO’s member countries have agreed on a draft “pandemic treaty” that sets gu...
After a lengthy regulatory back-and-forth, Eisai and Biogen's Alzheimer's drug i...
And other biotech news updates, brought to you by The Readout.
President Trump issued an executive order that aims to lower drug prices and boo...
Glycomine has bagged a $115 million series C round to continue the progress of i...
Essa Pharma is facing a call to wind down operations. Soleus Capital Management,...
In this tracker, Fierce Pharma is recording the regulatory progress of in-market...
Human medicines European public assessment report (EPAR): Spikevax (previously C...
Record of data processing activity for video-surveillance (CCTV) system
European Medicines Agency’s Data Protection Notice for the operation of video-su...
Human medicines European public assessment report (EPAR): Cometriq, cabozantinib...
The drug has hit several roadblocks in its European regulatory journey after its...
Human medicines European public assessment report (EPAR): Prevymis, letermovir, ...
EMA Agile governance model
Medicinal products for human use: monthly figures - March 2025
ICH M15 guideline on general principles for model-informed drug development - St...
The biotech is developing an experimental drug for the most common of a family o...
Report - Industry stakeholders and EU network experts surveys on early engagemen...